Search Results for "Money Control Of Sun Pharma"
Matching Channels
Airway Establishment and Control
Sustained high ventricular rates during persistent or permanent AF can lead to a deterioration in left ventricular function, hence the requirement for rate control. Historically, digoxin has been us...
Matching News
Sun Pharma To Buy All Of Israel’s Taro By Upping Offer By 60%
Sun Pharmaceutical Industries offered more money to buy Taro Pharma, apparently enough to gain the approval by the Israel-based firm’s board, giving the Indian drug manufacturer total control.
Obama Budget May Cause Big Pharma to Take Its Own Pain Meds
PharmaTech Talk reports what's in the new FY 2014 budget proposal that's in favor of Big Pharma? Not much apparently. First off, it appears FDA will be losing more money for drug oversight. Any added...
Where The Money Is: Armed With Pharma Cash, VenBio Seeks Pharma Customers
With $200 million under management and its first investment in the books, venBio is a new pharma-centric venture fund built for these strange times, when big drug companies have all the cash, all the...
Précis: With spiralling clinical trial costs, pharma companies are looking for savings. But less money spent is not necessarily money better spent....
Sun Pharma finally gains full control of Taro
Sun Pharmaceutical Industries (Sun Pharma) and Taro Pharmaceutical Industries (Taro) announced on 13 August 2012 that they have entered into a merger agreement together. India-based Sun Pharma has agr...
Where's our money? Pharma still waiting for €2bn in Greece
Pharmaceutical companies in Greece have still not been paid by public hospitals and the largest public health insurer EOPYY for drugs supplied in 2011 and 2012, even though the government received bai...
China’s Fosun Pharma Targets $650 Million IPO With Prudential Insurance As Cornerstone Investor
China’s largest non-state-owned pharma company Fosun Pharma commenced an initial global offering in Hong Kong, and nearly half of the money raised will be used for M&A. But the $650 million expe...
Fuji Pharma Of Japan To Buy Control Of Thai Contract Drug Maker OLIC
Japan’s Fuji Pharma plans to acquire OLIC, Thailand’s largest contract pharmaceutical maker, for just over $54 million, giving the Japanese firm total control.
Matching PubMed Articles
Minding Money: How Understanding of Value is Culturally Promoted.
Adding to the issues of cognitive economics (Cortes and Londoño IPBS: Integrative Psychological & Behavioral Science 43(2):178-184, 2009) and the social psychology of "shadow economics" (Salvatore et...
Background: There remains a long-standing argument regarding the need for money management strategies to control poor spending habits among people with substance use disorders. Objective: The objectiv...
The Pursuit of Happiness: Time, Money, and Social Connection.
Does thinking about time, rather than money, influence how effectively individuals pursue personal happiness? Laboratory and field experiments revealed that implicitly activating the construct of time...
Vision in Venture: Angels of innovation.
Convincing someone to risk money is often the first tangible evidence that a new technology has real market potential. While there's no shortage of impressive new technologies or startups in Israel to...
